Stevanato Group S.p.A. $STVN Shares Acquired by Royce & Associates LP

Royce & Associates LP lifted its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN) by 63.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 493,023 shares of the company’s stock after buying an additional 191,799 shares during the period. Royce & Associates LP owned approximately 0.16% of Stevanato Group worth $9,920,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of STVN. State of Wyoming raised its stake in Stevanato Group by 39,216.7% during the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after purchasing an additional 2,353 shares during the period. Quantbot Technologies LP acquired a new position in shares of Stevanato Group in the third quarter worth $68,000. Van Berkom & Associates Inc. increased its stake in shares of Stevanato Group by 50.6% in the third quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock worth $93,000 after acquiring an additional 1,215 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Stevanato Group by 1,268.7% in the second quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock worth $112,000 after acquiring an additional 4,250 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its stake in shares of Stevanato Group by 391.4% in the fourth quarter. Farther Finance Advisors LLC now owns 8,324 shares of the company’s stock worth $167,000 after acquiring an additional 6,630 shares during the last quarter.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. Citigroup dropped their price target on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday, March 5th. Wall Street Zen downgraded shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Morgan Stanley lowered their target price on shares of Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, March 6th. Weiss Ratings downgraded shares of Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 11th. Finally, Jefferies Financial Group set a $17.50 target price on shares of Stevanato Group in a research note on Tuesday, February 10th. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Stevanato Group currently has a consensus rating of “Hold”.

Stevanato Group Price Performance

Shares of STVN stock opened at €18.13 on Thursday. Stevanato Group S.p.A. has a 12-month low of €12.89 and a 12-month high of €28.00. The firm has a market capitalization of $5.49 billion, a price-to-earnings ratio of 30.73, a price-to-earnings-growth ratio of 1.66 and a beta of 0.75. The company has a quick ratio of 1.11, a current ratio of 1.63 and a debt-to-equity ratio of 0.21. The firm has a fifty day moving average of €15.87 and a 200-day moving average of €17.99.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Friday, May 8th. The company reported €0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.12 by (€0.01). Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The firm had revenue of €273.57 million during the quarter. During the same period last year, the business earned $0.10 earnings per share. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. On average, equities research analysts forecast that Stevanato Group S.p.A. will post 0.68 earnings per share for the current year.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.